Search Results

There are 3101853 results for: content related to: Allograft of stem cell-derived dopaminergic neurons for Parkinson's disease

  1. Dopamine-Angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease

    Movement Disorders

    Volume 28, Issue 10, September 2013, Pages: 1337–1342, Jose L. Labandeira-Garcia, Jannette Rodriguez-Pallares, Antonio Dominguez-Meijide, Rita Valenzuela, Begoña Villar-Cheda and Ana I. Rodríguez-Perez

    Version of Record online : 7 AUG 2013, DOI: 10.1002/mds.25614

  2. Developing dopaminergic cell therapy for Parkinson's disease—give up or move forward?

    Movement Disorders

    Volume 28, Issue 3, March 2013, Pages: 268–273, Olle Lindvall

    Version of Record online : 11 FEB 2013, DOI: 10.1002/mds.25378

  3. Metabolomics and the search for biomarkers in Parkinson's disease

    Movement Disorders

    Volume 28, Issue 12, October 2013, Pages: 1620–1621, Amy W. Amara and David G. Standaert

    Version of Record online : 18 SEP 2013, DOI: 10.1002/mds.25644

  4. Objective biomarkers of balance and gait for Parkinson's disease using body-worn sensors

    Movement Disorders

    Volume 28, Issue 11, 15 September 2013, Pages: 1544–1551, Fay B. Horak and Martina Mancini

    Version of Record online : 16 OCT 2013, DOI: 10.1002/mds.25684

  5. Deep brain stimulation for gait and postural symptoms in Parkinson's disease

    Movement Disorders

    Volume 28, Issue 11, 15 September 2013, Pages: 1609–1615, Monika Pötter-Nerger and Jens Volkmann

    Version of Record online : 16 OCT 2013, DOI: 10.1002/mds.25677

  6. Task force report: Scales for screening and evaluating tremor: Critique and recommendations

    Movement Disorders

    Volume 28, Issue 13, November 2013, Pages: 1793–1800, Rodger Elble, Peter Bain, Maria João Forjaz, Dietrich Haubenberger, Claudia Testa, Christopher G. Goetz, Albert F. G. Leentjens, Pablo Martinez-Martin, Anne Pavy-Le Traon, Bart Post, Cristina Sampaio, Glenn T. Stebbins, Daniel Weintraub and Anette Schrag

    Version of Record online : 3 SEP 2013, DOI: 10.1002/mds.25648

  7. A mir-153 binding site variation in SNCA in a patient with Parkinson's disease

    Movement Disorders

    Volume 28, Issue 12, October 2013, Pages: 1755–1756, Han-Joon Kim, Gibeom Park, Beom S. Jeon, Woong Yang Park and Young Eun Kim

    Version of Record online : 14 MAY 2013, DOI: 10.1002/mds.25505

  8. Usefulness of the Montreal Cognitive Assessment (MoCA) in Huntington's disease

    Movement Disorders

    Volume 28, Issue 12, October 2013, Pages: 1744–1747, Shea Gluhm, Jody Goldstein, Daniel Brown, Charles Van Liew, Paul E. Gilbert and Jody Corey-Bloom

    Version of Record online : 24 JUN 2013, DOI: 10.1002/mds.25578

  9. Improving memory in Parkinson's disease: A healthy brain ageing cognitive training program

    Movement Disorders

    Volume 28, Issue 8, July 2013, Pages: 1097–1103, Sharon L. Naismith, Loren Mowszowski, Keri Diamond and Simon J.G. Lewis

    Version of Record online : 29 APR 2013, DOI: 10.1002/mds.25457

  10. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale

    Movement Disorders

    Volume 28, Issue 5, May 2013, Pages: 668–670, Glenn T. Stebbins, Christopher G. Goetz, David J. Burn, Joseph Jankovic, Tien K. Khoo and Barbara C. Tilley

    Version of Record online : 13 FEB 2013, DOI: 10.1002/mds.25383

  11. You have full text access to this OnlineOpen article
    Global Action to reduce HIV stigma and discrimination

    Journal of the International AIDS Society

    Volume 16, Issue 3S2, November 2013,

    Version of Record online : 13 NOV 2013, DOI: 10.7448/IAS.16.3.18934

  12. Post-ischemic stroke Holmes' tremor of the upper limb

    Movement Disorders

    Volume 28, Issue 10, September 2013, Page: 1347, Stefan Kipfer and Susanna B. Frigerio

    Version of Record online : 7 AUG 2013, DOI: 10.1002/mds.25621

  13. You have full text access to this OnlineOpen article
    Rotigotine polyoxazoline conjugate SER-214 provides robust and sustained antiparkinsonian benefit

    Movement Disorders

    Volume 28, Issue 12, October 2013, Pages: 1675–1682, Karen L. Eskow Jaunarajs, David G. Standaert, Tacey X. Viegas, Michael D. Bentley, Zhihao Fang, Bekir Dizman, Kunsang Yoon, Rebecca Weimer, Paula Ravenscroft, Tom H. Johnston, Michael P. Hill, Jonathan M. Brotchie and Randall W. Moreadith

    Version of Record online : 3 SEP 2013, DOI: 10.1002/mds.25625

  14. Future of brain stimulation: New targets, new indications, new technology

    Movement Disorders

    Volume 28, Issue 13, November 2013, Pages: 1784–1792, Marwan Hariz, Patric Blomstedt and Ludvic Zrinzo

    Version of Record online : 7 OCT 2013, DOI: 10.1002/mds.25665

  15. Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutations

    Movement Disorders

    Volume 28, Issue 14, December 2013, Pages: 1966–1971, Roy N. Alcalay, Anat Mirelman, Rachel Saunders-Pullman, Ming-X Tang, Helen Mejia Santana, Deborah Raymond, Ernest Roos, Martha Orbe-Reilly, Tanya Gurevich, Anat Bar Shira, Mali Gana Weisz, Kira Yasinovsky, Maayan Zalis, Avner Thaler, Andres Deik, Matthew James Barrett, Jose Cabassa, Mark Groves, Ann L. Hunt, Naomi Lubarr, Marta San Luciano, Joan Miravite, Christina Palmese, Rivka Sachdev, Harini Sarva, Lawrence Severt, Vicki Shanker, Matthew Carrington Swan, Jeannie Soto-Valencia, Brooke Johannes, Robert Ortega, Stanley Fahn, Lucien Cote, Cheryl Waters, Pietro Mazzoni, Blair Ford, Elan Louis, Oren Levy, Llency Rosado, Diana Ruiz, Tsvyatko Dorovski, Michael Pauciulo, William Nichols, Avi Orr-Urtreger, Laurie Ozelius, Lorraine Clark, Nir Giladi, Susan Bressman and Karen S. Marder

    Version of Record online : 15 OCT 2013, DOI: 10.1002/mds.25647

  16. Dopamine overdose hypothesis: Evidence and clinical implications

    Movement Disorders

    Volume 28, Issue 14, December 2013, Pages: 1920–1929, David E. Vaillancourt, Daniel Schonfeld, Youngbin Kwak, Nicolaas I. Bohnen and Rachael Seidler

    Version of Record online : 9 OCT 2013, DOI: 10.1002/mds.25687

  17. Medication costs following subthalamic nucleus deep brain stimulation for Parkinson's disease

    Movement Disorders

    Volume 29, Issue 2, February 2014, Pages: 275–276, Mathias Toft and Espen Dietrichs

    Version of Record online : 21 MAY 2013, DOI: 10.1002/mds.25504

  18. 3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis

    Movement Disorders

    Volume 28, Issue 12, October 2013, Pages: 1653–1660, Peter A. LeWitt, Jia Li, Mei Lu, Thomas G. Beach, Charles H. Adler, Lining Guo and the Arizona Parkinson's Disease Consortium

    Version of Record online : 19 JUL 2013, DOI: 10.1002/mds.25555

  19. Pathogenic LRRK2 mutations in nuclear ageing—A new organelle to study in Parkinson's disease

    Movement Disorders

    Volume 28, Issue 10, September 2013, Pages: 1344–1345, John McKinley, Alan McCarthy and Timothy Lynch

    Version of Record online : 23 SEP 2013, DOI: 10.1002/mds.25595

  20. Movement disorders in women: A review

    Movement Disorders

    Volume 29, Issue 2, February 2014, Pages: 177–183, Marcie L. Rabin, Claire Stevens-Haas, Emilyrose Havrilla, Tanvi Devi and Roger Kurlan

    Version of Record online : 22 OCT 2013, DOI: 10.1002/mds.25723